Sequence Determinants in Hypoxia-inducible Factor-1α for Hydroxylation by the Prolyl Hydroxylases PHD1, PHD2, and PHD3
Open accessThe DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor induced by hypoxia. Under normoxic conditions, site-specific proline hydroxylation of the alpha subunits of HIF allows recognition by the von Hippel-Lindau tumor suppressor protein (VHL), a component of an E3 ubiquitin ligase complex that targets these subunits for degradation by the ubiquitin-proteasome pathway. Under hypoxic conditions, this hydroxylation is inhibited, allowing the alpha subunits of HIF to escape VHL-mediated degradation. Three enzymes, prolyl hydroxylase domain-containing proteins 1, 2, and 3 (PHD1, -2, and -3; also known as HIF prolyl hydroxylase 3, 2, and 1, respectively), have recently been identified that catalyze proline hydroxylation of HIF alpha subunits. These enzymes hydroxylate specific prolines in HIF alpha subunits in the context of a strongly conserved LXXLAP sequence motif (where X indicates any amino acid and P indicates the hydroxylacceptor proline). We report here that PHD2 has the highest specific activity toward the primary hydroxylation site of HIF-1alpha. Furthermore, and unexpectedly, mutations can be tolerated at the -5, -2, and -1 positions (relative to proline) of the LXXLAP motif. Thus, these results provide evidence that the only obligatory residue for proline hydroxylation in HIF-1alpha is the hydroxylacceptor proline itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,892
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
Research works printed but not linked: 3
- 9. Gu, Y.Z. ∙ Moran, S.M. ∙ Hogenesch, J.B. ... Gene Expr. 1998; 7:205-213 PubMed Google Scholar
- 33. Kivirikko, K.I. ∙ Pihlajaniemi, T. Adv. Enzymol. Relat. Areas Mol. Biol. 1998; 72:325-398 PubMed Google Scholar
- 34. Yu, F. ∙ White, S.B. ∙ Zhao, Q. ... Cancer Res. 2001; 61:4136-4142 PubMed Google Scholar
Cited by
Items 101–200 of 314
Martini, M., Teofili, L., Cenci, T., Giona, F., Torti, L., Rea, M., Foa, R., Leone, G., & Larocca, L. M. (2008) · Haematologica · doi:10.3324/haematol.13210 · Cited by 73
Kawabe, S., & Yokoyama, Y. (2011) · Marine Biotechnology · doi:10.1007/s10126-011-9394-3 · Cited by 77
PHD2: from hypoxia regulation to disease progression
Wielockx, B., & Meneses, A. (2016) · Hypoxia · doi:10.2147/hp.s53576 · Cited by 83
HIF-1α and iNOS levels in crucian carp gills during hypoxia-induced transformation
Sollid, J., Rissanen, E., Tranberg, H. K., Thorstensen, T., Vuori, K. A. M., Nikinmaa, M., & Nilsson, G. (2005) · Journal of Comparative Physiology B · doi:10.1007/s00360-005-0059-2 · Cited by 78
Barth, S., Edlich, F., Berchner‐Pfannschmidt, U., Gneuss, S., Jahreis, G., Hasgall, P. A., Fandrey, J., Wenger, R. H., & Camenisch, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032631 · Cited by 75
Analysis of the hypoxia-sensing pathway in Drosophila melanogaster
Arquier, N., Vigne, P., Duplan, E., Hsu, T., Thérond, P. P., Frelin, C., & D’Angelo, G. (2005) · Biochemical Journal · doi:10.1042/bj20050675 · Cited by 75
Leu‐574 of human HIF‐1α is a molecular determinant of prolyl hydroxylation
Kageyama, Y., Koshiji, M., To, K. K. W., Tian, Y., Ratcliffe, P. J., & Huang, L. E. (2004) · The FASEB Journal · doi:10.1096/fj.03-1233fje · Cited by 68
In vitro and In vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations
Rathmell, W. K., Hickey, M. M., Bezman, N. A., Chmielecki, C. A., Carraway, N. C., & Simon, M. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1430 · Cited by 64
Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2
Dey, A., Prabhudesai, S. N., Zhang, Y., Rao, G., Thirugnanam, K., Hossen, M. N., Dwivedi, S. K. D., Ramchandran, R., Mukherjee, P., & Bhattacharya, R. (2020) · Science Advances · doi:10.1126/sciadv.aaz8534 · Cited by 70
Mima, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174583 · Cited by 65
Overactivated NRF2 induces pseudohypoxia in hepatocellular carcinoma by stabilizing HIF-1α
Zheng, J., Kim, S., Saeidi, S., Kim, S. H., Fang, X., Lee, Y., Quispe, Y. N. G., Ngo, H. K. C., Kim, D., Kim, D., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.11.039 · Cited by 58
Aprelikova, O. N., Pandolfi, S., Tackett, S. A., Ferreira, M., Salnikow, K., Ward, Y., Risinger, J. I., Barrett, J. C., & Niederhuber, J. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0811 · Cited by 68
Pientka, F. K., Hu, J. J., Schindler, S., Brix, B., Thiel, A., Jöhren, O., Fandrey, J., Berchner‐Pfannschmidt, U., & Depping, R. (2012) · Journal of Cell Science · doi:10.1242/jcs.109041 · Cited by 69
Modeling the regulation of p53 activation by HIF‐1 upon hypoxia
Wang, P., Guan, D., Zhang, X., Liu, F., & Wang, W. (2019) · FEBS Letters · doi:10.1002/1873-3468.13525 · Cited by 65
Development of targeted angiogenic medicine
Loges, S., Roncal, C., & Carmeliet, P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03203.x · Cited by 67
Berchner-Pfannschmidt, U., Tug, S., Trinidad, B., Oehme, F., Yamac, H., Wotzlaw, C., Flamme, I., & Fandrey, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804390200 · Cited by 62
Percy, M. J., Mooney, S. M., McMullin, M. F., Flores, A. G., Lappin, T. R. J., & Lee, F. S. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-31 · Cited by 70
Self-citationSeven in Absentia Homolog 2 (Siah2) Protein Is a Regulator of NF-E2-related Factor 2 (Nrf2)*
Baba, K., Morimoto, H., & Imaoka, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438762 · Cited by 63
Chauvet, C., Bois-Joyeux, B., Berra, E., Pouysségur, J., & Danan, J.-L. (2004) · Biochemical Journal · doi:10.1042/bj20040709 · Cited by 68
Song, D., Li, L.-S., Heaton-Johnson, K. J., Arsenault, P. R., Master, S. R., & Lee, F. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.440552 · Cited by 61
Self-citationErythrocytosis associated with a novel missense mutation in the BPGM gene
Petousi, N., Copley, R. R., Lappin, T. R. J., Haggan, S. E., Bento, C. M., Cario, H., Percy, M. J., The WGS Consortium, Ratcliffe, P. J., Robbins, P. A., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.109306 · Cited by 59
Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
Michailidou, Z., Morton, N. M., Moreno Navarrete, J. M., West, C. C., Stewart, K. J., Fernández-Real, J. M., Schofield, C. J., Seckl, J. R., & Ratcliffe, P. J. (2015) · Diabetes · doi:10.2337/db14-0233 · Cited by 60
Activation of HIF-prolyl Hydroxylases by R59949, an Inhibitor of the Diacylglycerol Kinase
Temes, E., Martín-Puig, S., Acosta‐Iborra, B., Castellanos, M. C., Feijoo‐Cuaresma, M., Olmos, G., Aragonés, J., & Landázuri, M. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414694200 · Cited by 64
Redox state regulates HIF-1α and its DNA binding and phosphorylation in salmonid cells
Nikinmaa, M., Kangasjärvi, S., & Soitamo, A. J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01192 · Cited by 65
Furlow, P. W., Percy, M. J., Sutherland, S., Bierl, C., McMullin, M. F., Master, S. R., Lappin, T. R. J., & Lee, F. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808737200 · Cited by 58
Self-citationA fluorescence-based assay for 2-oxoglutarate-dependent oxygenases
McNeill, L. A., Bethge, L., Hewitson, K. S., & Schofield, C. J. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.09.019 · Cited by 62
Pereira, T., Zheng, X., Ruas, J. L., Tanimoto, K., & Poellinger, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209297200 · Cited by 59
Dioxygenases as O2-dependent regulators of the hypoxic response pathway
Dann, C. E., & Bruick, R. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.140 · Cited by 62
Ladroue, C., Hoogewijs, D., Gad, S., Carcenac, R., Storti, F., Barrois, M., Gimenez-Roqueplo, A.-P., Leporrier, M., Casadevall, N., Hermine, O., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.044644 · Cited by 55
“tion buffer containing co-factors (Fe, ascorbic acid and 2-oxoglutarate) as described previously.(24) The samples were incubated at”
MethodThe HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin
Masson, N., Appelhoff, R. J., Tuckerman, J. R., Tian, Y.-M., Demol, H., Puype, M., Vandekerckhove, J., Ratcliffe, P. J., & Pugh, C. W. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.040 · Cited by 56
Oligomycin inhibits HIF-1α expression in hypoxic tumor cells
Gong, Y., & Agani, F. H. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00443.2004 · Cited by 54
The role of PHD2 mutations in the pathogenesis of erythrocytosis
Gardie, B., Percy, M. J., Hoogewijs, D., Chowdhury, R., Bento, C., McMullin, M. F., Schofield, C. J., Lee, F. S., Richard, S., Arsenault, P. R., et al. (2014) · Hypoxia · doi:10.2147/hp.s54455 · Cited by 55
Self-citationvan der Wel, H., Ercan, A., & West, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500600200 · Cited by 53
Lee, H., Lee, T., Lee, N., Yang, E. G., Lee, C., Lee, J., Moon, E., Ha, J., & Park, H. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr034 · Cited by 50
Choi, K.-O., Lee, T., Lee, N., Kim, J., Yang, E. G., Yoon, J. M., Kim, J. H., Lee, T. G., & Park, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015271 · Cited by 53
Li, J., Yuan, W., Jiang, S., Ye, W., Yang, H., Shapiro, I. M., & Risbud, M. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611483 · Cited by 53
Wang, Z., Zhu, Q., Xia, M., Li, P., Hinton, S. J., & Li, N. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145896 · Cited by 50
Liu, Q., Möller, U., Flügel, D., & Kietzmann, T. (2004) · Blood · doi:10.1182/blood-2004-03-1017 · Cited by 48
Matsumoto, K., Imagawa, S., Obara, N., Suzuki, N., Takahashi, S., Nagasawa, T., & Yamamoto, M. P. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20733 · Cited by 52
Prolyl-hydroxylase 3: evolving roles for an ancient signaling protein
Domann, F. E., & Place (2013) · Hypoxia · doi:10.2147/hp.s50091 · Cited by 49
Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis
Avni, R., Cohen, B., & Neeman, M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1632 · Cited by 48
Muz, B., Larsen, H., Madden, L., Kiriakidis, S., & Paleolog, E. M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34479 · Cited by 46
SM-20, EGL-9, and the EGLN Family of Hypoxia-inducible Factor Prolyl Hydroxylases
Freeman, R. S., Hasbani, D. M., Lipscomb, E. A., Straub, J. A., & Xie, L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13758-7 · Cited by 52
IOP1, a novel hydrogenase-like protein that modulates hypoxia-inducible factor-1α activity
Huang, J., Song, D., Flores, A., Zhao, Q., Mooney, S. M., Shaw, L. M., & Lee, F. S. (2007) · Biochemical Journal · doi:10.1042/bj20060635 · Cited by 46
Self-citationLi, D., Hirsilä, M., Koivunen, P., Brenner, M. C., Xu, L., Yang, C., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410287200 · Cited by 43
Daly, L. A., Brownridge, P. J., Batie, M., Rocha, S., Sée, V., & Eyers, C. E. (2021) · Science Signaling · doi:10.1126/scisignal.abf6685 · Cited by 44
ERK5/BMK1 Is a Novel Target of the Tumor Suppressor VHL: Implication in Clear Cell Renal Carcinoma
Arias‐González, L., Moreno, I., Rubio‐del‐Campo, A., Serrano‐Oviedo, L., Valero, M. L., Esparís-Ogando, A., de la Cruz-Morcillo, M. Á., Melgar–Rojas, P., García‐Cano, J., Cimas, F. J., et al. (2013) · Neoplasia · doi:10.1593/neo.121896 · Cited by 47
Mitochondria and Hypoxia‐induced Gene Expression Mediated by Hypoxia‐inducible Factors
Chavez, A., Miranda, L. F., Pichiule, P., & Chavez, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.021 · Cited by 43
Genetic causes of erythrocytosis and the oxygen-sensing pathway
Lee, F. S. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.04.003 · Cited by 47
Self-citationNuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing
Depping, R., JELKMANN, W. E. B., & Kosyna, F. K. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1276-0 · Cited by 44
VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo
Lee, C. M., Hickey, M. M., Sanford, C. A., McGuire, C., Cowey, C. L., Simon, M. C., & Rathmell, W. K. (2009) · Oncogene · doi:10.1038/onc.2009.12 · Cited by 46
WEST, C., Wel, H. V. D., Sassi, S., & Gaucher, E. A. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.04.007 · Cited by 46
Hypoxia‐mediated Na‐K‐ATPase degradation requires von Hippel Lindau protein
Zhou, G., Dada, L. A., Chandel, N. S., Iwaï, K., Lecuona, E., Ciechanover, A. J., & Sznajder, J. I. (2007) · The FASEB Journal · doi:10.1096/fj.07-8369com · Cited by 44
Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression
Satija, S., Kaur, H., Tambuwala, M. M., Sharma, P., Vyas, M., Khurana, N., Sharma, N., Bakshi, H. A., Charbe, N. B., Zacconi, F. C. M., et al. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210120154929 · Cited by 40
Nakanishi, T., & Kuragano, T. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae051 · Cited by 39
Villar, D., Vara-Vega, A., Landázuri, M. O., & Del Peso, L. (2007) · Biochemical Journal · doi:10.1042/bj20071052 · Cited by 39
Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism
Nguyen, T.-L., & Durán, R. V. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.026 · Cited by 45
Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics
Nguyen, M. P., Lee, S., & Lee, Y. M. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0058-x · Cited by 40
Pappalardi, M. B., McNulty, D. E., Martin, J. D., Fisher, K. E., Jiang, Y., Burns, M. C., Zhao, H., Ho, T. F., Sweitzer, S. M., Schwartz, B., et al. (2011) · Biochemical Journal · doi:10.1042/bj20101201 · Cited by 41
Two new mutations in the HIF2A gene associated with erythrocytosis
Percy, M. J., Chung, Y. J., Harrison, C., Mercieca, J., Hoffbrand, A. V., Dinardo, C. L., Santos, P. C. J. L., Fonseca, G. H. H., Gualandro, S. F. M., Pereira, A. C., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23123 · Cited by 37
Self-citationHIF–prolyl hydroxylases and cardiovascular diseases
Banerjee, S. S., Thirunavukkarasu, M., Rishi, M. T., Sánchez, J. A., Maulik, N., & Maulik, G. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.673088 · Cited by 39
Differential expression of hypoxia pathway genes in honey bee (Apis mellifera L.) caste development
de Azevedo, S. V., Carantón, O. A. M., de Oliveira, T. L., & Hartfelder, K. (2010) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2010.09.004 · Cited by 38
Acceleration of Diabetic Wound Healing with PHD2- and miR-210-Targeting Oligonucleotides
Dallas, A., Trotsyuk, A. A., Ilves, H., Bonham, C. A., Rodrigues, M., Engel, K. W., Barrera, J. A., Kosaric, N., Stern‐Buchbinder, Z. A., White, A. J., et al. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0484 · Cited by 39
Hypoxic stress‐induced changes in adrenergic function: role of HIF1α
Tai, T. C., Wong‐Faull, D. C., Claycomb, R., & Wong, D. L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05978.x · Cited by 39
A central role for hypoxia-inducible factor (HIF)-2α in hepatic glucose homeostasis
Ramakrishnan, S. K., & Shah, Y. M. (2017) · Nutrition and Healthy Aging · doi:10.3233/nha-170022 · Cited by 39
Langhammer, S., Najjar, M., Hess‐Stumpp, H., & Thierauch, K. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0184-7 · Cited by 36
Analysis of HIF-prolyl hydroxylases binding to substrates
Landázuri, M. O., Vara-Vega, A., Vitón, M., Cuevas, Y., & del Peso, L. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.170 · Cited by 41
An alternatively spliced transcript of the PHD3 gene retains prolyl hydroxylase activity
Cervera, A. M., Apostolova, N., Luna-Crespo, F., Sanjuán-Pla, A., Garcia-Bou, R., & McCreath, K. J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.03.004 · Cited by 40
Fine tuning the HIF‐1 ‘global’ O2 sensor for hypobaric hypoxia in Andean high‐altitude natives
Hochachka, P. W., & Rupert, J. L. (2003) · BioEssays · doi:10.1002/bies.10261 · Cited by 38
Hypoxia-inducible factors: Crosstalk between their protein stability and protein degradation
Wei, W., & Yu, X. D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.009 · Cited by 34
Biochemistry of the hypoxia-inducible factor hydroxylases
Fiorini, G., & Schofield, C. J. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102428 · Cited by 35
Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma
Sato, E., Torigoe, T., Hirohashi, Y., Kitamura, H., Tanaka, T., Honma, I., Asanuma, H., Harada, K., Takasu, H., Masumori, N., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0466 · Cited by 32
Verma, A. M. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232895.28674.79 · Cited by 34
Terkhorn, S. P., Bohensky, J., Shapiro, I. M., Koyama, E., & Srinivas, V. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20873 · Cited by 34
Lewis, M. D., & Roberts, B. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206683 · Cited by 37
Hiwatashi, Y., Kanno, K., Takasaki, C., Goryo, K., Sato, T., Torii, S., Sogawa, K., & Yasumoto, K. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.09.005 · Cited by 31
Seifert, A., Katschinski, D. M., Tonack, S., Fischer, B., & Santos, A. N. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7001838 · Cited by 35
Schultz, K., Murthy, V., Tatro, J. B., & Beasley, D. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90393.2008 · Cited by 36
Willam, C., Nicholls, L. G., Ratcliffe, P. J., Pugh, C. W., & Maxwell, P. H. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.017 · Cited by 33
Fu, C., Tyagi, R., Chin, A. C., Rojas, T., Li, R.-J., Guha, P., Bernstein, I. A., Rao, F., Xu, R., Cha, J. Y., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311983 · Cited by 28
The Ternary Complex Factor Net Is Downregulated by Hypoxia and Regulates Hypoxia-Responsive Genes
Gross, C., Buchwalter, G., Dubois‐Pot‐Schneider, H., Cler, É., Zheng, H., & Wasylyk, B. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01867-06 · Cited by 27
Hasgall, P. A., Hoogewijs, D., Faza, M. B., Panse, V. G., Wenger, R. H., & Camenisch, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022107 · Cited by 27
Tanaka, T., Torigoe, T., Hirohashi, Y., Sato, E., Honma, I., Kitamura, H., Masumori, N., Tsukamoto, T., & Sato, N. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1593-7 · Cited by 27
Structural Analysis to Determine the Core of Hypoxia Response Network
Heiner, M., & Sriram, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008600 · Cited by 28
Chen, J., Liu, F., Li, H., Archacki, S. R., Gao, M., Liu, Y., Liao, S., Huang, M. N., Wang, J., Yu, S., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.08.011 · Cited by 25
Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors
Tug, S., Reyes, B. D., Fandrey, J., & Berchner‐Pfannschmidt, U. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.016 · Cited by 26
Identification of prolyl hydroxylation modifications in mammalian cell proteins
Arsenault, P. R., Heaton-Johnson, K. J., Li, L.-S., Song, D., Ferreira, V. S., Patel, N., Master, S. R., & Lee, F. S. (2015) · PROTEOMICS · doi:10.1002/pmic.201400398 · Cited by 26
Self-citationLippl, K., Boleininger, A., McDonough, M. A., Abboud, M. I., Tarhonskaya, H., Chowdhury, R., Loenarz, C., & Schofield, C. J. (2018) · Hypoxia · doi:10.2147/hp.s174655 · Cited by 26
Chen, D., Niu, Y., Liu, F., Yang, Y., Wang, X., Li, P., & Chen, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1163908 · Cited by 29
Townley, I. K., Karchner, S. I., Skripnikova, E., Wiese, T. E., Hahn, M. E., & Rees, B. B. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00402.2016 · Cited by 25
Wang, P., Zhang, X., Liu, F., & Wang, W. (2025) · Research · doi:10.34133/research.0651 · Cited by 30
Zhu, Q., Liu, M., Han, W., Li, P., Wang, Z., & Li, N. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01590.x · Cited by 24
Prolyl hydroxylase domain inhibitors: can multiple mechanisms be an opportunity for ischemic stroke?
Lanigan, S. M., & O'Connor, J. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.021 · Cited by 22
Chakraborty, A. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.012 · Cited by 25
Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells
Tang, C., Lei, H., Zhang, J., Liu, M., Jin, J., Luo, H., Xu, H., & Wu, Y. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1451279 · Cited by 24
HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
Wenger, R. H., Camenisch, G., Stiehl, D. P., & Katschinski, D. M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649411 · Cited by 24
The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer
Yu, M., Lun, J., Zhang, H., Zhu, L., Zhang, G., & Fang, J. S. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.105982 · Cited by 22
RSUME inhibits VHL and regulates its tumor suppressor function
Gerez, J., Tedesco, L., Bonfiglio, J. J., Fuertes, M., Barontini, M., Silberstein, S., Wu, Y., Renner, U., Páez-Pereda, M., Holsboer, F., et al. (2014) · Oncogene · doi:10.1038/onc.2014.407 · Cited by 24
Bhatia, M., Therese, C., Di, G., & Tonissen, K. F. (2013) · InTech eBooks · doi:10.5772/55185 · Cited by 23
Chen, Y., Dai, A., Hu, R., & Jiang, Y. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00174.x · Cited by 20
Metadata
- Authors
- Huang, J., Zhao, Q., Mooney, S. M., & Lee, F. S.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Lee, Frank S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 277
- Issue
- 42
- Pages
- 39792-39800
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC1828037
- OpenAlex
- W2127562514
- Cited by
- 307
- References
- 48
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 8 · 2023: 3 · 2022: 9 · 2021: 7 · 2020: 2 · 2019: 8 · 2018: 10 · 2017: 4 · 2016: 10 · 2015: 9 · 2014: 8 · 2013: 10 · 2012: 17
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6590 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01dk055672-04)
- National Cancer Institute (R01CA090261)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK55672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor-1α, prolyl hydroxylase, PHD1, PHD2, PHD3, proline hydroxylation, von Hippel-Lindau protein, E3 ubiquitin ligase, ubiquitin-proteasome degradation, sequence determinants
- MeSH terms
- Amino Acid Sequence, Animals, DNA-Binding Proteins, Genes, Dominant, Hydroxylation, Microscopy, Fluorescence, Molecular Sequence Data, Mutation, Peptides, Plasmids, Proline, Procollagen-Proline Dioxygenase, Protein Binding, Recombinant Proteins, Time Factors, Transcription Factors, Transcription, Genetic, Protein Biosynthesis, COS Cells, Amino Acid Motifs, Saccharomyces cerevisiae Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.